Cargando…
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312801/ https://www.ncbi.nlm.nih.gov/pubmed/35885020 http://dx.doi.org/10.3390/biomedicines10071715 |
_version_ | 1784753921559887872 |
---|---|
author | Scicali, Roberto Mandraffino, Giuseppe Scuruchi, Michele Lo Gullo, Alberto Di Pino, Antonino Ferrara, Viviana Morace, Carmela Aragona, Caterina Oriana Squadrito, Giovanni Purrello, Francesco Piro, Salvatore |
author_facet | Scicali, Roberto Mandraffino, Giuseppe Scuruchi, Michele Lo Gullo, Alberto Di Pino, Antonino Ferrara, Viviana Morace, Carmela Aragona, Caterina Oriana Squadrito, Giovanni Purrello, Francesco Piro, Salvatore |
author_sort | Scicali, Roberto |
collection | PubMed |
description | Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34+CPCs and pulse wave velocity (PWV) in a cohort of heterozygous familial hypercholesterolemia (HeFH) subjects. Methods: We determined CD34+ cell count and its change after PCSK9-i in 30 selected HeFH subjects and 30 healthy controls. Lipid profile and PWV were evaluated at baseline (T0), 6 months after intensive lipid lowering strategy (statin plus ezetimibe, T1), and after 6 months of optimized therapy with PCSK9-i (T2); CD34+ cell count was reported at T1 and T2. Results: At T1, the median value of CD34+ cells was not significantly different between HeFH subjects and controls, and the same result was obtained at T2. PWV was significantly reduced at T1 (ΔPWV − 14.8%, p < 0.001 vs. T0) and T2 (ΔPWV − 10.96%, p < 0.001 vs. T1). Dividing HeFH subjects into two groups of high- and low-CD34+ cell count, CD34+CPCs appeared to be polarized with a significant difference between the two groups (1.2 (0.46) vs. 4.74 (1.92), p < 0.001), also with respect to controls (both p < 0.001). This polarization was no longer observed at T2, and neither with respect to controls. ΔCD34+ was +67.4% in the low-CD34+ group and −39.24% in the high-CD34+ group (p < 0.001). Lastly, we found a significant correlation between ΔCD34+ cell number and ΔPWV in HeFH subjects (rho = −0.365, p < 0.05), particularly in the low-CD34+ group (rho = −0.681, p < 0.001). Conclusion: PCSK9-i exhibited favorable effects on CD34 + CPCs as was on PWV values in a cohort of FH subjects. Our preliminary findings suggest a possible positive role of this novel lipid-lowering strategy on vascular homeostasis. |
format | Online Article Text |
id | pubmed-9312801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93128012022-07-26 Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units Scicali, Roberto Mandraffino, Giuseppe Scuruchi, Michele Lo Gullo, Alberto Di Pino, Antonino Ferrara, Viviana Morace, Carmela Aragona, Caterina Oriana Squadrito, Giovanni Purrello, Francesco Piro, Salvatore Biomedicines Article Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34+CPCs and pulse wave velocity (PWV) in a cohort of heterozygous familial hypercholesterolemia (HeFH) subjects. Methods: We determined CD34+ cell count and its change after PCSK9-i in 30 selected HeFH subjects and 30 healthy controls. Lipid profile and PWV were evaluated at baseline (T0), 6 months after intensive lipid lowering strategy (statin plus ezetimibe, T1), and after 6 months of optimized therapy with PCSK9-i (T2); CD34+ cell count was reported at T1 and T2. Results: At T1, the median value of CD34+ cells was not significantly different between HeFH subjects and controls, and the same result was obtained at T2. PWV was significantly reduced at T1 (ΔPWV − 14.8%, p < 0.001 vs. T0) and T2 (ΔPWV − 10.96%, p < 0.001 vs. T1). Dividing HeFH subjects into two groups of high- and low-CD34+ cell count, CD34+CPCs appeared to be polarized with a significant difference between the two groups (1.2 (0.46) vs. 4.74 (1.92), p < 0.001), also with respect to controls (both p < 0.001). This polarization was no longer observed at T2, and neither with respect to controls. ΔCD34+ was +67.4% in the low-CD34+ group and −39.24% in the high-CD34+ group (p < 0.001). Lastly, we found a significant correlation between ΔCD34+ cell number and ΔPWV in HeFH subjects (rho = −0.365, p < 0.05), particularly in the low-CD34+ group (rho = −0.681, p < 0.001). Conclusion: PCSK9-i exhibited favorable effects on CD34 + CPCs as was on PWV values in a cohort of FH subjects. Our preliminary findings suggest a possible positive role of this novel lipid-lowering strategy on vascular homeostasis. MDPI 2022-07-15 /pmc/articles/PMC9312801/ /pubmed/35885020 http://dx.doi.org/10.3390/biomedicines10071715 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Scicali, Roberto Mandraffino, Giuseppe Scuruchi, Michele Lo Gullo, Alberto Di Pino, Antonino Ferrara, Viviana Morace, Carmela Aragona, Caterina Oriana Squadrito, Giovanni Purrello, Francesco Piro, Salvatore Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title | Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title_full | Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title_fullStr | Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title_full_unstemmed | Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title_short | Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units |
title_sort | effects of lipid lowering therapy optimization by pcsk9 inhibitors on circulating cd34+ cells and pulse wave velocity in familial hypercholesterolemia subjects without atherosclerotic cardiovascular disease: real-world data from two lipid units |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312801/ https://www.ncbi.nlm.nih.gov/pubmed/35885020 http://dx.doi.org/10.3390/biomedicines10071715 |
work_keys_str_mv | AT scicaliroberto effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT mandraffinogiuseppe effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT scuruchimichele effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT logulloalberto effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT dipinoantonino effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT ferraraviviana effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT moracecarmela effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT aragonacaterinaoriana effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT squadritogiovanni effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT purrellofrancesco effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits AT pirosalvatore effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits |